Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- AbbVie
- University of Bergen
- Lawrence Berkeley National Laboratory
- National University of Singapore
- Universidade de Coimbra
- University College Cork
- University of California
- University of Michigan
- Atlantic Technological University
- Flinders University
- Macquarie University
- Nanyang Technological University
- UNIVERSITY OF SYDNEY
- University of Adelaide
- University of Brighton
- University of Cincinnati
- University of St Andrews;
- University of Stavanger
- University of Sydney
- 9 more »
- « less
-
Field
-
» Biotechnology Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country Portugal Application Deadline 1 Oct 2025 - 23:59 (Europe/Lisbon) Type of Contract Temporary Job Status Full-time Hours
-
. Develop and implement control algorithms for distributed multi-agent system operations and spacecraft-based robotic manipulation. Perform research on spacecraft dynamics and control, including trajectory
-
engagement methodologies for the design of large language model (LLM) agents within digital health interventions. Stakeholders in this context include subject matter experts—such as clinicians, healthcare
-
.-based academic institutions who can be matched to projects within their area of scientific expertise for this unique 2-3-year assignment. Applicants who are awarded a postdoctoral position will have the
-
PhD Research Fellowship on Literature and Generative AI Apply for this job See advertisement UiB - Knowledge that shapes society Through robust and close interaction with the world around us
-
, researcher training, PhD summer schools, frequent symposia and exhibitions. About the PhD project and work tasks The successful candidate’s PhD project will investigate narrative through computational models
-
exhibitions. About the PhD project and work tasks The successful candidate’s PhD project will investigate narrative through computational models, for instance, those based on processes of storytelling, creative
-
uptake in more patient-relevant tumor models, and ultimately, more durable efficacy for patients. AbbVie is highly invested in antibody-based therapies, including bispecifics, antibody-drug conjugates, and
-
.-based academic institutions who can be matched to projects within their area of scientific expertise for this unique 2-3-year assignment. Applicants who are awarded a postdoctoral position will have the